Special and Differential Treatment in Biotech
Still ploughing on with Biotech! I am struck today by the panel's (excessively) cautious approach to the interpretation of the special and differential treatment obligation in Article 10.1 of the SPS Agreement. The panel concluded that while Members must take the interests of developing countries into account